Philip Morris nabs over 20% of Vectura’s shares; Oncopeptides drug may be headed for adcomm, CEO says

About a week after Vectura’s board of directors said they would unanimously back a Philip Morris takeover, the tobacco giant now has control of more than a fifth of the respiratory drugmaker’s shares.

Shareholders with 22.61% of Vectura’s shares have tendered their stock to Philip Morris, Reuters

Click to view original post